Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcyphosine-like protein (CAPSL) is a calcium-binding protein with EF-hand domains predicted to localize to the cytoplasm and play multifaceted roles in cell biology, including calcium ion signaling, regulation of adipocyte differentiation, fat metabolism, cell migration, and immune response modulation[1][3][5]. Genetic association studies have implicated CAPSL loci in autoimmune diseases like type 1 diabetes and Graves’ disease[1], while functional studies show down-regulation in adipose tissue of patients with multiple symmetric lipomatosis, with experimental evidence supporting its role in adipogenesis, lipogenesis, autophagy, and sirtuin-1 expression[1][4]. No drugs currently target CAPSL directly, and it is not considered a classical druggable target such as a receptor, enzyme, or ion channel[1][4][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcyphosine-like protein (CAPSL).